Sharenet Sites 
Sharenet Sites
Form 8-K current report
ASP ISOTOPES INC.
(Incorporated in the State of Delaware,
United States of America)
(Delaware file number 6228898)
Ticker Symbol: NASDAQ: ASPI
ISIN: US00218A1051
LEI: 6488WHV94BZ496OZ3219
JSE Share Code: ISO
("ASPI" or "the Company")
FORM 8-K CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, ASPI stockholders are advised
that a Form 8-K has been filed with the U.S. Securities and Exchange Commission.
Item 8.01. Other Events.
On December 17, 2025, ASP Isotopes Inc. (the "Company" or "ASP Isotopes") issued a press release
announcing that all required regulatory approvals and clearances have been obtained for the Company's
proposed offer to acquire all of the issued ordinary shares of Renergen Limited ("Renergen"), pursuant to
a scheme of arrangement under South African law pursuant to which Renergen shareholders will receive
0.09196 new ASP Isotopes shares for each Renergen share held on the record date (the "Scheme"). A
copy of the press release is attached to the Current Report on Form 8-K as Exhibit 99.1 and is incorporated
therein by reference.
A copy of the Form 8-K can also be found at: Inline Viewer: ASP Isotopes Inc. 8-K 2025-12-17
The Company has a primary listing on the Nasdaq and a secondary listing on the Main Board of the JSE.
17 December 2025
Sponsor
Valeo Capital Proprietary Limited
Date: 17-12-2025 05:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
